Urteste S.A. (URT.WA)

PLN 92.8

(-1.28%)

Operating Expenses Summary of Urteste S.A.

  • Urteste S.A.'s latest annual operating expenses in 2023 was 5.96 Million PLN , up 61.47% from previous year.
  • Urteste S.A.'s latest quarterly operating expenses in 2024 Q2 was 550 Thousand PLN , down -73.81% from previous quarter.
  • Urteste S.A. reported a annual operating expenses of 3.69 Million PLN in annual operating expenses 2022, up 67.63% from previous year.
  • Urteste S.A. reported a annual operating expenses of 2.2 Million PLN in annual operating expenses 2021, up 114.85% from previous year.
  • Urteste S.A. reported a quarterly operating expenses of 550 Thousand PLN for 2024 Q2, down -73.81% from previous quarter.
  • Urteste S.A. reported a quarterly operating expenses of 1.38 Million PLN for 2023 Q4, down -8.23% from previous quarter.

Annual Operating Expenses Chart of Urteste S.A. (2023 - 2019)

Historical Annual Operating Expenses of Urteste S.A. (2023 - 2019)

Year Operating Expenses Operating Expenses Growth
2023 5.96 Million PLN 61.47%
2022 3.69 Million PLN 67.63%
2021 2.2 Million PLN 114.85%
2020 1.02 Million PLN 206.9%
2019 334.37 Thousand PLN 0.0%

Peer Operating Expenses Comparison of Urteste S.A.

Name Operating Expenses Operating Expenses Difference
Bioceltix S.A. 15.38 Million PLN 61.208%
BIOTON S.A. 57.55 Million PLN 89.631%
Captor Therapeutics Spolka Akcyjna 79.91 Million PLN 92.532%
Mabion S.A. 59.52 Million PLN 89.973%
Molecure S.A. 31.73 Million PLN 81.192%
NanoGroup S.A. 7.82 Million PLN 23.748%
Pharmena S.A. -32.76 Million PLN 118.215%
Poltreg S.A. 15.47 Million PLN 61.435%
Pure Biologics Spólka Akcyjna 29.14 Million PLN 79.522%
Ryvu Therapeutics S.A. 4.73 Million PLN -25.96%
Synthaverse S.A. 26.35 Million PLN 77.354%